Products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC67316	S-2238 H-D-Phe-Pip-Arg-pNA acetate Featured
DC67317	S-2222 N-benzoyl-ile-glu-gly-arg P-nitroanilide acetate Featured
DC67318	S-2366 Pyr-Pro-Arg-pNA hydrochloride Featured
DC67319	S-2403 PyroGlu-Phe-Lys-pNA hydrochloride Featured
DC67320	S-2732 Suc-lle-Glu (y-Pip) -Gly-Arg-pNA hydrochloride Featured
DC60809	6Ac1-C12 Featured	The 6Ac1-C12 LNPs exhibit a pKa of ~6.0, enabling pH-responsive endosomal escape. They demonstrate high stability (maintaining ~100 nm size for 30 days at 4°C) and efficient mRNA encapsulation. With slightly negative surface charge, these nanoparticles show serum resistance. The liver-targeted formulation (4-component) achieves 98% hepatic mRNA expression, primarily in endothelial (60%) and Kupffer cells. The cholesterol-free 3-component lung-targeted version eliminates hepatic accumulation while enabling 71% transfection in pulmonary endothelial cells. Both formulations maintain structural integrity post-dialysis and show low cytotoxicity, with lung-targeted LNPs exhibiting reduced lipoprotein adsorption for enhanced organ specificity.
DC60810	Lipid head 503 (1,3-Propanediamine, N,N'-bis(2-aminoethyl)-N,N'-dimethyl-) Featured
DC60815	TH35 Featured	TH35 is a novel class of CRBN-recruiting cGAS-targeting PROTAC degrader with IC50 of 1.8 and 4.8 μM,in THP1-Lucia ISG and RAW-Lucia ISG cells, respectively. TH35 exhibits strong anti-inflammatory effects in the DSS-induced UC mice model.
DC60816	UNC9426 Featured	UNC9426 is a novel and potent TYRO3 inhibitor with IC50 of 2.1 nM and Ambit selectivity score (S50 (1.0 μM) = 0.026), respectively. UNC9426 shows favorable pharmacokinetic properties in mice.
DC67321	1,3,5-Tribromoadamantane Featured
DC60817	AM-9747 Featured	AM-9747 is an MTA-cooperative PRMT5 inhibitor with IC50 of 9.5 nM in the MTAP-del viability assay and shows outstanding 75-fold selectivity over the corresponding isogenic MTAP-WT cellular viability. AM-9747 also shows a significant oral antitumor effect in mouse models employing PDXs.
DC67322	GL67 pentahydrochloride Featured	GL67 (N4-Spermine cholesteryl carbamate) in its pentahydrochloride form is a cationic lipid with versatile applications in the delivery of nucleic acid agents, vaccines, and gene transfection, owing to its efficient encapsulation and transport capabilities.GL67 (N4-Spermine cholesteryl carbamate) in its pentahydrochloride form is a cationic lipid with versatile applications in the delivery of nucleic acid agents, vaccines, and gene transfection, owing to its efficient encapsulation and transport capabilities.
DC67323	1,9-Bis-Boc-1,5,9-triazanonane Featured
DC67325	(S)-ACE-OH Featured	(S)-ACE-OH is a molecular glue exhibiting anticancer properties by facilitating the degradation of nucleoporins and disrupting nucleocytoplasmic transport. It achieves this by inducing an interaction between the E3 ubiquitin ligase TRIM21 and the nucleoporin NUP98.
DC67326	LYG-409 Featured	LYG-409 is an orally active degrader of GSPT1, demonstrating significant efficacy against acute myeloid leukemia and prostate cancer in vivo, with tumor growth inhibition (TGI) rates of 94.34% and 104.49%, respectively. In vitro, LYG-409 effectively inhibits KG-1 cells by degrading GSPT1, exhibiting an IC50 of 9.50 nM and a DC50 of 7.87 nM.
DC67327	Lenalidomide hemihydrate Featured	Lenalidomide hemihydrate (CC-5013 hemihydrate), a derivative of thalidomide, functions as a molecular glue and is an orally active immunomodulator. It acts as a ligand for the ubiquitin E3 ligase cereblon (CRBN), facilitating the selective ubiquitination and degradation of the lymphoid transcription factors IKZF1 and IKZF3 through the CRBN-CRL4 ubiquitin ligase complex. Lenalidomide hemihydrate specifically inhibits the growth of mature B-cell lymphomas, including multiple myeloma, and promotes the release of IL-2 from T cells.
DC67328	ALV1 Featured	ALV1 is a molecular glue degrader targeting Ikaros (IKZF1) and Helios (IKZF2), with DC50 values of 2.5 nM and 10.3 nM, respectively. It binds to CRBN with an IC50 of 0.55 µM and induces CRBN-Helios dimerization. ALV1 is a valuable tool for studying the properties and functions of regulatory T cells (Treg cells).
DC67329	TMX1 Featured	TMX1 is a covalent molecular glue degrader targeting BRD4. It selectively recruits DCAF16 to the BRD4BD2 domain, resulting in the degradation of BRD4.
DC67330	MYC degrader 1 Featured	MYC degrader 1 (compound A80.2HCl) is an orally available molecular glue degrader targeting MYC, with significant anti-tumor activity. It restores pRB1 protein function and re-establishes the sensitivity of MYC-overexpressing cancer cells to CDK4/6 inhibitors.
DC67331	MMH2 Featured	MMH2 is a novel BRD4 molecular glue degrader that operates by recruiting the CUL4 and DCAF16 ligases to the second bromodomain of BRD4 (BRD4BD2).
DC67332	GBD-9 Featured	GBD-9 is a dual-mechanism degrader that effectively targets BTK and GSPT1 by recruiting the E3 ligase cereblon (CRBN). It functions both as a PROTAC molecule to degrade BTK and as a molecular glue to induce GSPT1 degradation. GBD-9 demonstrates potent inhibition of cancer cell growth.
DC67333	MYC degrader 1 TFA Featured	MYC degrader 1 TFA (compound A80.2HCl) is an orally available molecular glue degrader targeting MYC, exhibiting significant anti-tumor activity. It restores pRB1 protein function and re-establishes the sensitivity of MYC-overexpressing cancer cells to CDK4/6 inhibitors.
DC67334	Tz-Thalidomide Featured	Tz-Thalidomide is a tetrazine-functionalized derivative of thalidomide (HY-14658) designed for targeted protein degradation applications. This bifunctional molecule serves as an E3 ligase ligand while maintaining binding affinity for BRD4, with IC50 values of 46.25 μM (BRD4-1) and 62.55 μM (BRD4-2).
DC67335	MMH1 Featured	MMH1 is a first-in-class molecular glue degrader that specifically targets the second bromodomain of BRD4 (BRD4BD2) through an innovative mechanism of action. By simultaneously engaging both BRD4BD2 and the CUL4-DCAF16 E3 ubiquitin ligase complex, MMH1 induces targeted protein degradation with exceptional specificity.
DC67336	HbF inducer 2 Featured	HbF inducer 2 is an orally bioavailable molecular glue that selectively degrades the WIZ transcription factor (DC50 = 13 nM in human erythroid precursors) and upregulates fetal hemoglobin (HbF) expression (EC50 = 100 nM). By inducing WIZ proteolysis, it disrupts the γ-globin repressor complex, demonstrating promising pharmacokinetics in cynomolgus monkeys for potential β-hemoglobinopathy therapy.
DC67337	VNPP433-3β Featured	VNPP433-3β is a first-in-class molecular glue degrader that simultaneously targets androgen receptor (AR), its splice variants (AR-Vs), and Mnk1/2 kinases for proteasomal degradation. This multimodal agent demonstrates potent anti-proliferative activity in castration-resistant prostate cancer (CRPC) models, with GI50 values of 0.2–0.31 μM in LNCaP, C4-2B, and CWR22Rv1 cells. Its robust in vivo efficacy, evidenced by tumor growth inhibition in CWR22Rv1 xenografts, is supported by favorable pharmacokinetics in CD-1 mice.
DC67338	Pan-RAS-IN-2 Featured	Pan-rasin-2 (Compound 6A) is a novel molecular glue that selectively targets RAS, a critical oncoprotein frequently mutated in cancers. It exhibits potent anti-proliferative effects in RAS-driven cancer cell lines by disrupting oncogenic signaling.
DC67339	PLX-3618 Featured	PLX-3618 is a targeted molecular glue that induces the degradation of BRD4, a key epigenetic regulator implicated in cancer. It achieves potent BRD4 degradation (DC50 = 12.2 nM) by recruiting the E3 ubiquitin ligase adapter DCAF11, which tags BRD4 with polyubiquitin chains for proteasome-mediated destruction.
DC67340	Naphthyridine carbamate dimer Featured	Naphthyridine Carbamate Dimer (NCD) is a synthetic DNA molecular glue engineered to induce programmable structural rearrangements in functional DNA. Unlike conventional small-molecule binders, NCD operates by non-covalently crosslinking specific DNA sequences, enforcing conformational changes that modulate DNA’s biological activity.
DC67341	MMH2-NR Featured	MMH2-NR serves as an essential negative control compound for MMH2, a novel DCAF16-dependent BRD4 degrader. While MMH2 mediates targeted protein degradation by recruiting the CUL4-DCAF16 E3 ligase complex to bromodomain-containing protein 4 (BRD4), MMH2-NR is structurally analogous but lacks degradation activity, making it critical for mechanistic validation.

Products

Customized Consultation X

Your information is safe with us. * Required Fields.